TMED ranks 2nd and PYZ 10th of 35 funds in the US Active Sector Category.
PYZ vs TMED
0.0%by weight
TMED −0.16pt a year
0.60%0.44%
TMED 4.0×the volume
1.85K7.43K
PYZ vs TMED Performance
+7.7%+20.6%
- PYZ 0.60%
- TMED 0.44%, better
- PYZ $63M
- TMED $34M
- PYZ +7.7%
- TMED +20.6%, better
- PYZ 0.51%
- TMED
- PYZ 43
- TMED 112
- PYZ 1.85K sh
- TMED 7.43K sh, better
- PYZ $112.31
- TMED $34.31
ETF.net Grade
| Pillar | PYZ | TMED |
|---|---|---|
| Cost | B56 | A82Higher |
| Mission | ||
| Risk | D26 | B55Higher |
| Tradability | B64Higher | B59 |
| Holdings | A89 | A91Higher |
| Durability | A75Higher | D35 |
Rank among US Active Sector funds
Same Category. PYZ and TMED are both graded against the same 35 US Active Sector funds, so their Grades compare head to head.
Our read on each fund
PYZB
TMEDB
In short
PYZ Materials, ranked by momentum. PYZ scores US basic-materials stocks on relative strength, holds at least 30 of the strongest, and weights them by momentum score rather than market cap. Reshuffled quarterly since 2006.
Stated mandate
PYZ The fund normally invests at least 90% of its total assets in securities comprising its index. The index selects at least 30 Nasdaq US securities showing relative strength, or momentum.
Why people hold it
Worth knowing
PYZ vs TMED Holdings
How PYZ and TMED differ
0.0%
Shared holdings make up 0.0% of PYZ and 0.0% of TMED.
Level by level
- Sector0.0%
- Holdings0.0%
- Country96.1%
Sector
| Sector | More in PYZMore in TMED | PYZ | TMED |
|---|---|---|---|
| Health Care | TMED +99.9 points | 0.0% | 99.9% |
| Materials | PYZ +83.3 points | 83.3% | 0.0% |
| Industrials | PYZ +16.7 points | 16.7% | 0.0% |
| Technology | TMED +0.1 points | 0.0% | 0.1% |
Country, concentration and asset class
Country
| Country | More in PYZMore in TMED | PYZ | TMED |
|---|---|---|---|
| United States | PYZ +3.9 points | 100.0% | 96.1% |
| Switzerland | TMED +1.8 points | 0.0% | 1.8% |
| Germany | TMED +0.7 points | 0.0% | 0.7% |
| Canada | TMED +0.6 points | 0.0% | 0.6% |
| Other countries (3) | TMED +0.8 points | 0.0% | 0.8% |
Concentration
- PYZ37.5%
- TMED37.0%
- PYZ42
- TMED110
Asset class
- PYZ
- Equity
- TMED
- Equity
Holdings
- Only in PYZ42
- In both0
- Only in TMED110
Only in PYZ
42 securities, 99.9% of PYZ by weight
- Reliance Inc4.92%
- ATI Inc4.30%
- Nucor Corp4.06%
- Newmont Corp3.68%
- Royal Gold Inc3.63%
- CF Industries Holdings Inc3.62%
- Air Products and Chemicals Inc3.46%
- Carpenter Technology Corp3.32%
- Freeport-McMoRan Inc3.28%
- DuPont de Nemours Inc3.25%
- Hecla Mining Co3.21%
- Linde PLC2.78%
- Element Solutions Inc2.75%
- Cleveland-Cliffs Inc2.71%
- Steel Dynamics Inc2.68%
- Sensient Technologies Corp2.49%
- Ecolab Inc2.43%
- Dow Inc2.40%
- Perimeter Solutions Inc2.38%
- NewMarket Corp2.36%
- Ashland Inc2.31%
- International Flavors & Fragrances Inc2.23%
- LyondellBasell Industries NV2.22%
- Vylor Inc2.18%
- Cabot Corp2.14%
- Louisiana-Pacific Corp2.12%
- Ingevity Corp2.11%
- Materion Corp2.02%
- Alcoa Corp1.97%
- Century Aluminum Co1.90%
- MP Materials Corp1.80%
- Worthington Enterprises Inc1.76%
- Commercial Metals Co1.70%
- Innospec Inc1.63%
- Kaiser Aluminum Corp1.61%
- Quaker Chemical Corp1.53%
- Mosaic Co/The1.51%
- Coeur Mining Inc1.49%
- Chemours Co/The1.38%
- Corteva Inc0.34%
- Invesco Government & Agency Portfolio0.28%
- Securities Lending - Bnym0.00%
Only in TMED
110 securities, 97.1% of TMED by weight
- Eli Lilly & Co Common Stock5.94%
- UnitedHealth Group Inc Common Stock USD.015.20%
- Alnylam Pharmaceuticals Inc Common Stock USD.013.89%
- Insulet Corp Common Stock USD.0013.80%
- Thermo Fisher Scientific Inc Common Stock USD1.03.42%
- Gilead Sciences Inc Common Stock USD.0013.09%
- Agilent Technologies Inc Common Stock USD.013.08%
- Intuitive Surgical Inc Common Stock USD.0013.00%
- Elanco Animal Health Inc Common Stock2.74%
- Danaher Corp Common Stock USD.012.46%
- Cencora Inc Common Stock USD.012.40%
- Ascendis Pharma A/S Common Stock DKK1.02.37%
- West Pharmaceutical Services Common Stock USD.252.31%
- Cytokinetics Inc Common Stock USD.0012.24%
- Waters Corp Common Stock USD.012.17%
- Vaxcyte Inc Common Stock USD.0012.09%
- Dexcom Inc Common Stock USD.0012.05%
- Denali Therapeutics Inc Common Stock USD.011.75%
- Dyne Therapeutics Inc Common Stock USD.00011.72%
- Moonlake Immunotherapeutics Common Stock USD.00011.70%
- Boston Scientific Corp Common Stock USD.011.64%
- Cabaletta Bio Inc Common Stock USD.000011.62%
- Shattuck Labs Inc Common Stock USD.00011.58%
- Idexx Laboratories Inc Common Stock USD.11.51%
- Abbott Laboratories Common Stock1.51%
- Biogen Inc Common Stock USD.00051.38%
- Immunome Inc Common Stock USD.00011.28%
- Mckesson Corp Common Stock USD.011.23%
- Humana Inc Common Stock USD.16666661.04%
- Adaptive Biotechnologies Common Stock USD.00011.01%
- Prime Medicine Inc Common Stock USD.000010.98%
- Oruka Therapeutics Inc Common Stock USD.0010.96%
- Revvity Inc Common Stock USD1.00.90%
- Onkure Therapeutics Inc A Common Stock USD.00010.81%
- Cvs Health Corp Common Stock USD.010.80%
- Erasca Inc Common Stock USD.00010.80%
- Repligen Corp Common Stock USD.010.78%
- Cg Oncology Inc Common Stock0.76%
- Ionis Pharmaceuticals Inc Common Stock USD.0010.75%
- Immatics NV Common Stock0.74%
- Biontech SE Adr Adr0.72%
- Freenome Inc Common Stock USD.00010.71%
- Sartorius AG Common Stock0.67%
- Billiontoone Inc Class A Common Stock USD.000010.64%
- Dianthus Therapeutics Inc Common Stock USD.0010.63%
- Xenon Pharmaceuticals Inc Common Stock0.59%
- Disc Medicine Inc Common Stock USD.00010.52%
- Kailera Therapeutics Inc Common Stock USD.000010.47%
- Kardigan Inc Common Stock USD.000010.45%
- Corvus Pharmaceuticals Inc Common Stock USD.00010.41%
Weight gaps
PYZ and TMED share no securities.
How we measure overlap
Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.
PYZ vs TMED Cost
Overpaying PYZ vs TMED
$2,965
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
PYZ 0.60%
$11,817
TMED 0.44%
$8,852
Cost over time
Year by year
| Year | PYZ | TMED | Overpaying |
|---|---|---|---|
| 10 | $1,076 | $794 | $282 |
| 20 | $4,116 | $3,061 | $1,055 |
| 30 | $11,817 | $8,852 | $2,965 |
- 0.60%PYZ
- 0.44%TMED, cheaper
- Middle half of US Active Sector funds
- Median 0.61%
TMED 7th cheapest of 35 funds
PYZ 15th cheapest of 35 funds
PYZ vs TMED Dividends
- PYZ 0.51%
- TMED
- PYZ $0.57
- TMED
- PYZ $0.15
- TMED $0.16
- PYZ Sep 21, 2026
- TMED Dec 23, 2025
- PYZ Sep 25, 2026
- TMED Dec 26, 2025
- PYZ Quarterly
- TMED Irregular
Distribution history
PYZ vs TMED Risk
Fall from peak · 5 years
Risk facts
- Volatility
- PYZ 20.5%TMED 14.7%
- Return per unit of risk
- PYZ 0.61TMED 1.50
- Worst fall
- PYZ −33.0%TMED −11.1%
- Market sensitivity
- PYZ 1.28TMED 0.46
Popular comparisons
- 0.60% · 0.17%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.44% · 0.17%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.60% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.44% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.60% · 0.14%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.44% · 0.14%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.